[HTML][HTML] IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia …

G Marcucci, K Maharry, YZ Wu… - Journal of clinical …, 2010 - ncbi.nlm.nih.gov
G Marcucci, K Maharry, YZ Wu, MD Radmacher, K Mrózek, D Margeson, KB Holland…
Journal of clinical oncology, 2010ncbi.nlm.nih.gov
IDH1 and IDH2 Gene Mutations Identify Novel Molecular Subsets Within De Novo
Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study -
PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage
MyNCBI Homepage Main Content Main Navigation Search PMC Full-Text Archive Search
in PMC Advanced Search User Guide Journal List J Clin Oncol PMC2881719 Other
Formats PubReader PDF (1.6M) Actions Cite Collections Share Permalink Copy …
Abstract
Purpose
To analyze the frequency and associations with prognostic markers and outcome of mutations in IDH genes encoding isocitrate dehydrogenases in adult de novo cytogenetically normal acute myeloid leukemia (CN-AML).
ncbi.nlm.nih.gov